CASC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cascadian Therapeutics Inc's quarterly common stock increased from Mar. 2016 ($353.86 Mil) to Jun. 2016 ($353.86 Mil) but then stayed the same from Jun. 2016 ($353.86 Mil) to Sep. 2016 ($353.86 Mil).
Cascadian Therapeutics Inc's annual common stock increased from Dec. 2013 ($353.85 Mil) to Dec. 2014 ($353.86 Mil) but then stayed the same from Dec. 2014 ($353.86 Mil) to Dec. 2015 ($353.86 Mil).
Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.
The par value of common stocks is meaningless. It is usually set at an absurdly low number.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Cascadian Therapeutics Inc Annual Data
Cascadian Therapeutics Inc Quarterly Data